Australia markets closed

Medivolve Inc. (MEDVF)

Other OTC - Other OTC Delayed price. Currency in USD
Add to watchlist
0.0130+0.0104 (+400.00%)
At close: 02:42PM EDT

Medivolve Inc.

65 Queen Street West
Suite 800
Toronto, ON M5H 2M5
Canada
416-861-2267
https://www.medivolve.ca

Sector(s)Healthcare
IndustryDiagnostics & Research
Full-time employees25

Key executives

NameTitlePayExercisedYear born
Mr. David PreinerPresident & CEO2.95MN/AN/A
Mr. Neil SaidGeneral Counsel752.82kN/A1979
Mr. Indivar PathakChief Operating Officer - Collection Sites605.65kN/AN/A
Pamela KennedySr. Advisor Government Affairs159.45kN/AN/A
Mr. Aaron AtinConsultant154.79kN/A1986
Dominique VaillancourtManager of Investor RelationsN/AN/AN/A
Amounts are as of 31 December 2022, and compensation values are for the last fiscal year ending on that date. Pay includes salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.

Description

Medivolve Inc. is a principal investment firm. It prefers to invest in healthcare technology, industrials, information technology. Medivolve Inc., formerly known as QuestCap Inc, was founded in 2005 and is based in Toronto, Canada.

Corporate governance

Medivolve Inc.’s ISS governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while 10 indicates higher governance risk.